AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

July 31, 2007

Conditions

Breast Cancer

Interventions

BIOLOGICAL

filgrastim

BIOLOGICAL

pegfilgrastim

DRUG

cediranib maleate

DRUG

cyclophosphamide

DRUG

docetaxel

DRUG

doxorubicin hydrochloride

OTHER

laboratory biomarker analysis

PROCEDURE

conventional surgery

PROCEDURE

neoadjuvant therapy

Trial Locations (2)

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00310089 - AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer | Biotech Hunter | Biotech Hunter